| 104.14 Data as of May 10 |  +5.95 / +6.06%Today’s Change | 81.82 Today|||52-Week Range 119.54 | +11.09% Year-to-Date |
| Cramer: Biotech Makes a Comeback May 10 / TheStreet.com | Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner May 09 / TheStreet.com |
| Biotech Makes a Comeback May 10 / TheStreet.com | Shire - rarity value May 03 / FT.com |
| Previous close | 98.19 |
| Today’s open | 98.52 |
| Day’s range | 97.90 - 104.21 |
| Volume | 2,343,407 |
| Average volume (3 months) | 1,922,967 |
| Market cap | $19.2B |
| Dividend yield | -- |
| Earnings growth (last year) | +40.66% |
| Earnings growth (this year) | +38.62% |
| Earnings growth (next 5 years) | +23.60% |
| Revenue growth (last year) | +41.93% |
| P/E ratio | 71.8 |
| Price/Sales | 15.92 |
| Price/Book | 9.70 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire PLC | -0.18 | -0.19% |
| VRTXVertex Pharmaceutica... | +3.65 | +4.75% |
| ZTSZoetis Inc | -0.37 | -1.10% |
| VRXValeant Pharmaceutic... | +0.78 | +1.07% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $254.8M |
| Net profit margin | 22.73% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer, Treasurer & Director Leonard Bell, MD |
Chief Financial Officer & Executive Vice President Vikas Sinha, MBA, CPA |
Corporate headquarters Cheshire, Connecticut |
.
